JP Morgan Chase
OXFD

JP Morgan Chase’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

JP Morgan Chase’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,231
Closed -$97K – 6136
2020
Q3 		$97K Sell
8,231
-91,955
-92% -$1.22M ﹤0.01% 4708
2020
Q2 		$1.3M Sell
100,186
-1,993
-2% -$23.9K ﹤0.01% 3364
2020
Q1 		$946K Sell
102,179
-13,174
-11% -$184K ﹤0.01% 3425
2019
Q4 		$1.92M Buy
115,353
+656
+0.6% +$10.6K ﹤0.01% 3420
2019
Q3 		$1.91M Buy
114,697
+20,343
+22% +$281K ﹤0.01% 3454
2019
Q2 		$1.3M Buy
94,354
+3,157
+3% +$48.3K ﹤0.01% 3683
2019
Q1 		$1.57M Buy
91,197
+70,976
+351% +$1.12M ﹤0.01% 3509
2018
Q4 		$259K Sell
20,221
-60,042
-75% -$911K ﹤0.01% 4471
2018
Q3 		$1.3M Buy
80,263
+14,904
+23% +$213K ﹤0.01% 3742
2018
Q2 		$842K Buy
65,359
+45,805
+234% +$619K ﹤0.01% 3927
2018
Q1 		$243K Buy
19,554
+14,092
+258% +$172K ﹤0.01% 4302
2017
Q4 		$76K Buy
+5,462
New +$80K ﹤0.01% 4761
2017
Q2 		– Sell
-30,468
Closed -$472K – 5345
2017
Q1 		$472K Sell
30,468
-12,382
-29% -$177K ﹤0.01% 3741
2016
Q4 		$641K Buy
+42,850
New +$602K ﹤0.01% 3637

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase's OXFD Position: Q4 2020 in Review

JP Morgan Chase sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 8,231 shares — an estimated $97K sold.

JP Morgan Chase first reported a position in OXFD in Q4 2016 and held it in 14 quarters. The position peaked at $1.92M in Q4 2019. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

  • JP Morgan Chase reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 8,231 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $97K.
  • JP Morgan Chase first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2016 and held it in 14 quarters.
  • JP Morgan Chase's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.92M in Q4 2019.
  • 60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.